UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer

Journal of the National Comprehensive Cancer Network, 2013-06, Vol.11 (6), p.670-678

2013

Volltextzugriff (PDF)

NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming

Molecular cell, 2011-11, Vol.44 (4), p.609-620

2011

Volltextzugriff (PDF)

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Human pathology, 2013-07, Vol.44 (7), p.1341-1349

2013

Volltextzugriff (PDF)

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

Human pathology, 2013-06, Vol.44 (6), p.959-965

2013

Volltextzugriff (PDF)

PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System

Clinical cancer research, 2013-10, Vol.19 (19), p.5413-5422

2013

Volltextzugriff (PDF)

Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner

Biochemical journal, 2013-01, Vol.449 (2), p.459-468

2013

Volltextzugriff (PDF)

Circulating Tumor DNA: Measurement and Clinical Utility

Annual review of medicine, 2018-01, Vol.69 (1), p.223-234

2018

Volltextzugriff (PDF)

Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy

Human pathology, 2012-07, Vol.43 (7), p.1003-1011

2012

Volltextzugriff (PDF)

Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (18), p.8460-8467

2007

Volltextzugriff (PDF)

P21 and p27: roles in carcinogenesis and drug resistance

Expert reviews in molecular medicine, 2008-07, Vol.10, p.e19-e19, Article e19

2008

Volltextzugriff (PDF)

Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (11), p.5337-5344

2007

Volltextzugriff (PDF)

Tamoxifen-stimulated growth of breast cancer due to p21 loss

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (1), p.288-293

2008

Volltextzugriff (PDF)

Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells

Endocrinology (Philadelphia), 2018-01, Vol.159 (1), p.285-296

2018

Volltextzugriff (PDF)

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models

Breast cancer research : BCR, 2017-05, Vol.19 (1), p.60-60, Article 60

2017

Volltextzugriff (PDF)

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Clinical cancer research, 2016-02, Vol.22 (4), p.993-999

2016

Volltextzugriff (PDF)

Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations

Cancer letters, 2019-02, Vol.442, p.373-382

2019

Volltextzugriff (PDF)

Personalized postdoctoral fellowship care

Nature biotechnology, 2018-09, Vol.36 (9), p.900-902

2018

Volltextzugriff (PDF)

Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (11), p.3248-3261

2013

Volltextzugriff (PDF)

Genomic Landscapes of Human Breast and Colorectal Cancers

Science (American Association for the Advancement of Science), 2007-11, Vol.318 (5853), p.1108-1113

2007

Volltextzugriff (PDF)

High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients

Breast cancer research and treatment, 2018-04, Vol.168 (3), p.695-702

2018

Volltextzugriff (PDF)

Call for action: expanding global access to hereditary cancer genetic testing

The lancet oncology, 2022-09, Vol.23 (9), p.1124-1126

2022

Volltextzugriff (PDF)

Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science (American Association for the Advancement of Science), 2006-10, Vol.314 (5797), p.268-274

2006

Volltextzugriff (PDF)

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA

Cancer, 2016-10, Vol.122 (19), p.3015-3023

2016

Volltextzugriff (PDF)

Somatic alterations as the basis for resistance to targeted therapies

The Journal of pathology, 2014-01, Vol.232 (2), p.244-254

2014

Volltextzugriff (PDF)

Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1768, p.209

2018

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(171)
Life Sciences & Biomedicine
(149)
Humans
(117)
Oncology
(83)
Female
(69)
Mutation
(56)
Breast Cancer
(52)
Breast Neoplasms - Genetics
(40)
Tumors
(39)
Animals
(34)
Cancer
(34)
Mice
(30)
Cell Line, Tumor
(28)
Breast Neoplasms - Metabolism
(27)
Biological And Medical Sciences
(26)
Breast Neoplasms - Pathology
(26)
Multidisciplinary Sciences
(21)
Phosphatidylinositol 3-Kinases - Genetics
(21)
Science & Technology - Other Topics
(21)
Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer

NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System

Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner

Circulating Tumor DNA: Measurement and Clinical Utility

Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy

Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras-mediated transformation

P21 and p27: roles in carcinogenesis and drug resistance

Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death

Tamoxifen-stimulated growth of breast cancer due to p21 loss

Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations

Personalized postdoctoral fellowship care

Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

Genomic Landscapes of Human Breast and Colorectal Cancers

High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients

Call for action: expanding global access to hereditary cancer genetic testing

Consensus Coding Sequences of Human Breast and Colorectal Cancers

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA

Somatic alterations as the basis for resistance to targeted therapies

Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients

Suchergebnisse filtern